Tenet Strikes Surgery Center Deal Worth $1.2B
Tenet Healthcare Corp (NYSE:THC) has agreed to acquire SurgCenter Development for approximately $1.2 billion. Tenet and its subsidiary, United Surgical Partners…
Tenet, USPI To Acquire SurgCenter Development And Establish Long-Term Development Partnership
Tenet Healthcare Corporation (NYSE:THC), and its subsidiary United Surgical Partners International (USPI), today announced that they have entered into a definitive agreement with the principals of SurgCenter Development
A Look Into Healthcare Sector Value Stocks
Understanding Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Expert Ratings For Tenet Healthcare
Within the last quarter, Tenet Healthcare (NYSE:THC) has observed the following analyst ratings:
Citigroup Maintains Buy on Tenet Healthcare, Raises Price Target to $91
Citigroup maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $88 to $91.
What 7 Analyst Ratings Have To Say About Tenet Healthcare
Over the past 3 months, 7 analysts have published their opinion on Tenet Healthcare (NYSE:THC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Credit Suisse Maintains Outperform on Tenet Healthcare, Raises Price Target to $95
Credit Suisse analyst Jonathan Yong maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $88 to $95.
SVB Leerink Maintains Market Perform on Tenet Healthcare, Lowers Price Target to $78
SVB Leerink analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Market Perform and lowers the price target from $80 to $78.
Tenet Achieves Quarterly Operating Income Of $1B, Raises FY21 Outlook
Tenet Healthcare Corp (NYSE: THC) saw many of its key financial metrics improve in Q3 FY21.
